Maynard Um
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on vTv Therapeutics (VTVT): "Street overlooking small molecule portfolio"
-
-
-
-
-
-
-
vTv Therapeutics (VTVT) Misses Q2 EPS by 92c
-
-
-
-
-
-
-
vTv Therapeutics (VTVT) Misses Q3 EPS by 88c
-
-
-
-
435,836 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

